TR200103475T2 - Aril ikameli nitrogen heterosaykıllı yeni karboksilik asit türevleri - Google Patents

Aril ikameli nitrogen heterosaykıllı yeni karboksilik asit türevleri

Info

Publication number
TR200103475T2
TR200103475T2 TR2001/03475T TR200103475T TR200103475T2 TR 200103475 T2 TR200103475 T2 TR 200103475T2 TR 2001/03475 T TR2001/03475 T TR 2001/03475T TR 200103475 T TR200103475 T TR 200103475T TR 200103475 T2 TR200103475 T2 TR 200103475T2
Authority
TR
Turkey
Prior art keywords
carboxylic acid
acid derivatives
aryl substituted
substituted nitrogen
nitrogen heterocycle
Prior art date
Application number
TR2001/03475T
Other languages
English (en)
Inventor
Amberg Wilhelm
Kettschau Georg
Original Assignee
Basf Aktiengeselllschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Aktiengeselllschaft filed Critical Basf Aktiengeselllschaft
Publication of TR200103475T2 publication Critical patent/TR200103475T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/30—Only oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Mevcut bulus, formül I'in kjarboksilik asit türevleriyle ilgilidir. (Formül). Öyle ki burada ikame ediciler tarifte açiklanan anlamlara sahiplerdir; söz konusu karboksilik asit türevlerinin hazirlanmasi ve bu türevlerin endotelin alici antagonistleri olarak kullanilmasi.
TR2001/03475T 1999-06-01 2000-05-19 Aril ikameli nitrogen heterosaykıllı yeni karboksilik asit türevleri TR200103475T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19924892A DE19924892A1 (de) 1999-06-01 1999-06-01 Neue Carbonsäurederivate mit arylsubstituierten Stickstoffheterocyclen, ihre Herstellung und Verwendung als Endothelin Rezeptorantagonisten

Publications (1)

Publication Number Publication Date
TR200103475T2 true TR200103475T2 (tr) 2002-04-22

Family

ID=7909761

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/03475T TR200103475T2 (tr) 1999-06-01 2000-05-19 Aril ikameli nitrogen heterosaykıllı yeni karboksilik asit türevleri

Country Status (20)

Country Link
EP (1) EP1181281A2 (tr)
JP (1) JP2003500476A (tr)
KR (1) KR20020006049A (tr)
CN (1) CN1359376A (tr)
AR (1) AR022047A1 (tr)
AU (1) AU765345B2 (tr)
BG (1) BG106154A (tr)
BR (1) BR0011105A (tr)
CA (1) CA2375666A1 (tr)
CZ (1) CZ20014312A3 (tr)
DE (1) DE19924892A1 (tr)
HK (1) HK1047102A1 (tr)
HU (1) HUP0201387A3 (tr)
IL (1) IL146800A0 (tr)
MX (1) MXPA01012284A (tr)
NO (1) NO20015762L (tr)
PL (1) PL355112A1 (tr)
SK (1) SK17552001A3 (tr)
TR (1) TR200103475T2 (tr)
WO (1) WO2000073276A2 (tr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120035196A1 (en) * 2009-04-22 2012-02-09 Kenji Negoro Carboxylic acid compound

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR199901416T2 (tr) * 1996-12-18 1999-08-23 Basf Aktiengesellschaft Heterosiklik karbonikasit türevleri.
DE19726146A1 (de) * 1997-06-19 1998-12-24 Basf Ag Neue ß-Amino und ß-Azidopcarbonsäurederivate, ihre Herstellung und Verwendung als Endothelinrezeptorantagonisten
BR9811631A (pt) * 1997-09-04 2000-09-26 Basf Ag Derivado de ácido carboxìlico e uso do mesmo
DE19806438A1 (de) * 1998-02-17 1999-08-19 Basf Ag Neue Carbonsäurederivate mit 5-substituiertem Pyrimidinring, ihre Herstellung und Verwendung
DE19809144A1 (de) * 1998-03-04 1999-09-09 Basf Ag Neue unsymmetrisch substituierte Carbonsäurederivate, ihre Herstellung und Verwendung als gemischte ET¶LAMBDA¶/ET¶B¶-Rezeptorantagonisten
DE19836044A1 (de) * 1998-08-10 2000-02-17 Basf Ag Neue Carbonsäurederivate, die Ketoseitenketten tragen, ihre Herstellung und Verwendung als Endothelin-Rezeptorantagonisten

Also Published As

Publication number Publication date
IL146800A0 (en) 2002-07-25
HK1047102A1 (zh) 2003-02-07
SK17552001A3 (sk) 2002-08-06
AU5395900A (en) 2000-12-18
EP1181281A2 (de) 2002-02-27
BR0011105A (pt) 2002-03-05
CA2375666A1 (en) 2000-12-07
MXPA01012284A (es) 2002-07-30
CN1359376A (zh) 2002-07-17
DE19924892A1 (de) 2000-12-07
AR022047A1 (es) 2002-09-04
HUP0201387A3 (en) 2004-12-28
NO20015762L (no) 2001-12-13
CZ20014312A3 (cs) 2003-02-12
WO2000073276A2 (de) 2000-12-07
WO2000073276A3 (de) 2001-05-10
JP2003500476A (ja) 2003-01-07
AU765345B2 (en) 2003-09-18
NO20015762D0 (no) 2001-11-26
HUP0201387A2 (en) 2002-08-28
PL355112A1 (en) 2004-04-05
KR20020006049A (ko) 2002-01-18
BG106154A (en) 2002-08-30

Similar Documents

Publication Publication Date Title
BR0014352A (pt) Cetoenóis espirocìclicos substituìdos por trifluormetila
PT1007523E (pt) Derivados indole e 2,3-di-ridroindole, sua preparacao e utilizacao
EE05105B1 (et) Fenlfenantridiinid, nende kasutamine ravimite valmistamiseks ning neid sisaldav ravim
TR200002542T2 (tr) Meta-azasiklik amino benzoik asit bileşikleri ve bunların integrin antagonistleri olan türevleri
EE200000033A (et) Uudsed tetrasoolderivaadid
NO20052520D0 (no) Nye sulfamider
TR200400645T4 (tr) İkameli Fenil Piperazin türevleri, Bunların Hazırlanması ve kullanımları
TR199802039T2 (tr) Yeni alfa-hidroksilik asit türevleri, üretimleri ve kullanimlari.
TR28332A (tr) Arilasetik asit türevleri.
ATE311389T1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
DE60019894D1 (de) Phenantrhridin-n-oxides mit pde-iv hemmender wirkung
ATE259813T1 (de) Triazolopyrimidinderivate
TR200001182T2 (tr) Yeni karbonik asit türevleri, üretimleri ve kullanımları.
ATE295352T1 (de) Phenanthridine-n-oxide mit pde-iv hemmender wirkung
TR199901416T2 (tr) Heterosiklik karbonikasit türevleri.
TR199903159T2 (tr) Yeni -Amino ve -Azido karbonik asit türevleri.
TR200103475T2 (tr) Aril ikameli nitrogen heterosaykıllı yeni karboksilik asit türevleri
TR200001080T2 (tr) 2 ile ikame edilmiş 1,2-Benisotiyazol türevleri ve bunların serrotonın antagonistleri
TR200101780T2 (tr) Yeni ß-amido ve ß-sülfonamido karboksilik asit türevleri.
TR200001365T2 (tr) Yeni heterosiklik ikame edilmiş a-hidroksikarbonik asit türevleri
TR200000602T2 (tr) Yeni karbonik asit türevleri, üretimleri ve kullanımları.
NO20021502L (no) Kinazolinoner
FI971831A0 (fi) Heterosyklillä substituoituja propeenihappojohdannaisia NMDA-antagonisteina
DE59803066D1 (de) Substituierte benzyloxyimino-verbindungen
NO20004075L (no) Substituerte pyrimidin-2-yloksy-karboksylsyrederivater, fremstilling av disse og deres anvendelse som endotelin- antagonister